A novel FexA variant from a canine Staphylococcus pseudintermedius isolate that does not confer florfenicol resistance

  1. Gómez-Sanz, E. 1
  2. Kadlec, K. 2
  3. Feßler, A.T. 2
  4. Zarazaga, M. 1
  5. Torres, C. 1
  6. Schwarz, S. 2
  1. 1 Universidad de La Rioja
    info

    Universidad de La Rioja

    Logroño, España

    ROR https://ror.org/0553yr311

  2. 2 Institute of Farm Animal Genetics, Friedrich-Loeffler-Institut (FLI), Neustadt-Mariensee, Germany
Revista:
Antimicrobial Agents and Chemotherapy

ISSN: 0066-4804

Año de publicación: 2013

Volumen: 57

Número: 11

Páginas: 5763-5766

Tipo: Artículo

beta Ver similares en nube de resultados
DOI: 10.1128/AAC.00948-13 SCOPUS: 2-s2.0-84885906775 WoS: WOS:000325764000081 GOOGLE SCHOLAR

Otras publicaciones en: Antimicrobial Agents and Chemotherapy

Repositorio institucional: lock_openAcceso abierto Editor

Proyectos relacionados

Resistencia bacteriana a antimicrobianos en ambiente y fauna salvaje. Mecanismos de resistencia y líneas genéticas emergentes e implicaciones en salud humana

2013/00001/001

Resumen

Transposon Tn558 integrated in the chromosomal radC gene was detected for the first time in Staphylococus pseudintermedius. It carried a novel fexA variant (fexAv) that confers only chloramphenicol resistance. The exporter FexAv exhibited two amino acid substitutions, Gly33Ala and Ala37Val, both of which seem to be important for substrate recognition. Sitedirected mutagenesis that reverted the mutated base pairs to those present in the original fexA gene restored the chloramphenicol-plus-florfenicol resistance phenotype. Copyright © 2013, American Society for Microbiology. All Rights Reserved.